Personal information

No personal information available

Activities

Collapse all

Employment (8)

Vlaams Instituut voor Biotechnologie: Leuven, BE

2016 to present | Head of the Laboratory of Tumor Microenvironment and Therapeutic Resistance (Center for Cancer biology)
Employment
Source: Self-asserted source
Gabriele Bergers

University of California: CA, CA, US

2016 to present | Adjunct Full Professor (Neurosurgery)
Employment
Source: Self-asserted source
Gabriele Bergers

UCSF Helen Diller Family Comprehensive Cancer Center: San Francisco, CA, US

2016 to present | Adjunct Full Professor (Brain Tumor Research Center)
Employment
Source: Self-asserted source
Gabriele Bergers

KU Leuven: Leuven, BE

2016 to present | Professor (Deprtment of Oncology)
Employment
Source: Self-asserted source
Gabriele Bergers

University of California: CA, CA, US

2009 to present | Faculty member (Department of Anatomy)
Employment
Source: Self-asserted source
Gabriele Bergers

University of California: CA, CA, US

2002 to present | Faculty member (Biomedical Sciences)
Employment
Source: Self-asserted source
Gabriele Bergers

University of California: CA, CA, US

1999 to 2001 | Assistant Research Biochemist (Hormone Research Institute)
Employment
Source: Self-asserted source
Gabriele Bergers

University of California: CA, CA, US

1994 to 1999 | Postdoctoral Fellow (Hormone Research Institute)
Employment
Source: Self-asserted source
Gabriele Bergers

Education and qualifications (2)

University of Vienna: Vienna, AT

1989 to 1993 | PhD Biology - Genetics (Institute for Molecular Pathology)
Education
Source: Self-asserted source
Gabriele Bergers

Ludwig Maximilian University of Munich: Munich, DE

1984 to 1989 | Master in Biology (Biology)
Education
Source: Self-asserted source
Gabriele Bergers

Professional activities (4)

KU Leuven: Leuven, BE

2016 to present | Board member (Department of Oncology)
Membership
Source: Self-asserted source
Gabriele Bergers

Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven Campus Gasthuisberg: Leuven, Flanders, BE

2016 to present | Member (Leuven Comprehensive Cancer Center (LKI))
Membership
Source: Self-asserted source
Gabriele Bergers

North American Vascular Biology Organization: Germantown, Maryland, US

2016 | Judah Folkman Award
Distinction
Source: Self-asserted source
Gabriele Bergers

UCSF Sandler Program: San Francisco, CA, US

2006 | Opportunity Award (Basic Sciences)
Distinction
Source: Self-asserted source
Gabriele Bergers

Funding (22)

Unraveling and targeting microglia-driven glioma invasion

2019-01 to 2022-12 | Grant
Stichting Tegen Kanker (Brussels, BE)
Source: Self-asserted source
Gabriele Bergers

Vascular immunomodulation in cancer

2018-01 to 2021-12 | Grant
Fonds Wetenschappelijk Onderzoek (Brussels, BE)
GRANT_NUMBER:

G0A0818N
Source: Self-asserted source
Gabriele Bergers

Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

2018 to 2022 | Grant
Horizon 2020 Framework Programme (Brussels, BE)
Source: Self-asserted source
Gabriele Bergers

Exploring CXCL14 as cancer therapy

2016-04 to 2018-03 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

in vivo shRNA library screening to identify resistance pathways in glioma

2016-04 to 2018-03 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Inter-regulatory function of immune-modulation and angiogenesis in cancer

2016 to 2021 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Using PDAC and GBM models to explore nove identified cMet:CDCP1 hetero-complex

2014-12 to 2016-11 | Grant
Roche (Munich, DE)
Source: Self-asserted source
Gabriele Bergers

Autophagy as a microenvironmental regulator of tumorigenesis and resistance

2014-09 to 2019-08 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Revealing means of patient stratficiation to obtiain a better response rate to anti-Met and bevacizumab therapy in GBM patients

2014-01 to 2015-12 | Grant
Genentech (CA, CA, US)
Source: Self-asserted source
Gabriele Bergers

Tumor cell and microenvironment changes causing antiangiogenic therapy resistance

2013-09 to 2018-05 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Implications of innate immune cells in PNET resistance

2013-06 to 2015-06 | Grant
American Association for Cancer Research (PA, PA, US)
Source: Self-asserted source
Gabriele Bergers

Is the inflammation signature a read-out for early stage detection of PDAC and metastatic seeding?

2012-11 to 2014-10 | Grant
Bernard and Irene Schwartz Foundation (NY, NY, US)
Source: Self-asserted source
Gabriele Bergers

Biophysical and molecular dialogue of glioma cells and the brain microenvironment

2011-08 to 2016-07 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis

2011-04 to 2016-03 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Characterization of Circulating Endothelial Cells, Pericytes and Stem Cells in Patients with Breast Cancer Receiving Anti-Angiogenic Therapy

2008-10 to 2011-09 | Grant
Breast Cancer Research Foundation (NY, NY, US)
Source: Self-asserted source
Gabriele Bergers

Mechanisms and therapeutic targeting in evasive resistance to antiangiogenic drugs

2008-07 to 2013-06 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Perivascular dissemination of Glioblastoma cells

2006-07 to 2011-06 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Does a defect in asymmetric stem cell division cause cancer initiation?

2005-12 to 2006-11 | Grant
Sandler Foundation (CA, CA, US)
Source: Self-asserted source
Gabriele Bergers

PDGFRbeta+-Perivascular tumor cells in tumor angiogenesis

2004-08 to 2009-07 | Grant
NIH Clinical Center (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Understanding perivascular invasion mechanisms in glioblastoma

2004-07 to 2006-03 | Grant
Goldhirsh Foundation (CA, CA, US)
Source: Self-asserted source
Gabriele Bergers

Identification of tumor-endothelial specific factors in low-grade astrocytomas and glioblastoma multiforme.

2004-04 to 2006-03 | Award
V Foundation for Cancer Research (NC, NC, US)
Source: Self-asserted source
Gabriele Bergers

Hypoxia and Neovascularization: Cause or Consequence of GBM Progression?

2002-07 to 2004-06 | Grant
Sidney Kimmel Foundation for Cancer Research (Md., Md., US)
Source: Self-asserted source
Gabriele Bergers

Works (50 of 68)

Items per page:
Page 1 of 2

The Pan-Tumor Vasculature under the Transcriptomic Magnifying Glass

Cancer Research
2024-11-04 | Journal article
DOI: 10.1158/0008-5472.CAN-24-3219
Contributors: Krish Skandha Gopalan; Gabriele Bergers
Source: check_circle
Crossref

Targeting the tumour vasculature: from vessel destruction to promotion

Nature Reviews Cancer
2024-10 | Journal article
DOI: 10.1038/s41568-024-00736-0
Contributors: Sophie Guelfi; Kairbaan Hodivala-Dilke; Gabriele Bergers
Source: check_circle
Crossref

High endothelial venules in cancer: Regulation, function, and therapeutic implication

Cancer Cell
2023-03 | Journal article
DOI: 10.1016/j.ccell.2023.02.002
Contributors: Gerlanda Vella; Yichao Hua; Gabriele Bergers
Source: check_circle
Crossref

R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis

Cell Research
2022-08-05 | Journal article
DOI: 10.1038/s41422-022-00708-9
Contributors: Nuray Bögürcü-Seidel; Gabriele Bergers
Source: check_circle
Crossref

Tumors vs. Chronic Wounds: An Immune Cell's Perspective

Frontiers in Immunology
2019-09-12 | Journal article
DOI: 10.3389/fimmu.2019.02178
Part of ISSN: 1664-3224
Source: Self-asserted source
Gabriele Bergers

Peptide-guided nanoparticles for glioblastoma targeting

Journal of Controlled Release
2019-08 | Journal article
DOI: 10.1016/j.jconrel.2019.06.018
Part of ISSN: 0168-3659
Source: Self-asserted source
Gabriele Bergers

Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis

Annual Review of Physiology
2019-02-10 | Journal article
DOI: 10.1146/annurev-physiol-020518-114721
Part of ISSN: 0066-4278
Part of ISSN: 1545-1585
Source: Self-asserted source
Gabriele Bergers

A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma

Nature Cell Biology
2018-10 | Journal article
DOI: 10.1038/s41556-018-0183-3
Part of ISSN: 1465-7392
Part of ISSN: 1476-4679
Source: Self-asserted source
Gabriele Bergers

The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer

Seminars in Cancer Biology
2018-10 | Journal article
DOI: 10.1016/j.semcancer.2018.06.002
Contributors: Rindert Missiaen; Massimiliano Mazzone; Gabriele Bergers
Source: check_circle
Crossref

Where Have All the T Cells Gone?

Immunity
2018-10 | Journal article
DOI: 10.1016/j.immuni.2018.10.006
Part of ISSN: 1074-7613
Source: Self-asserted source
Gabriele Bergers

Consensus guidelines for the use and interpretation of angiogenesis assays

Angiogenesis
2018-08 | Journal article
DOI: 10.1007/s10456-018-9613-x
Part of ISSN: 0969-6970
Part of ISSN: 1573-7209
Source: Self-asserted source
Gabriele Bergers

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules

The Journal of Pathology
2018-06 | Journal article
DOI: 10.1002/path.5080
Part of ISSN: 0022-3417
Source: Self-asserted source
Gabriele Bergers

Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors

Oncotarget
2017-11-21 | Journal article
DOI: 10.18632/oncotarget.22276
Part of ISSN: 1949-2553
Source: Self-asserted source
Gabriele Bergers

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer

Proceedings of the National Academy of Sciences
2017-10-10 | Journal article
DOI: 10.1073/pnas.1701821114
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Source: Self-asserted source
Gabriele Bergers

Glioblastoma: To Target the Tumor Cell or the Microenvironment?

Glioblastoma
2017-09-22 | Book chapter
DOI: 10.15586/codon.glioblastoma.2017.ch16
Part of ISBN: 9780994438126
Source: Self-asserted source
Gabriele Bergers

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

Science Translational Medicine
2017-04-12 | Journal article
DOI: 10.1126/scitranslmed.aak9679
Part of ISSN: 1946-6234
Part of ISSN: 1946-6242
Source: Self-asserted source
Gabriele Bergers

Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations

Cold Spring Harbor Symposia on Quantitative Biology
2016 | Journal article
DOI: 10.1101/sqb.2016.81.030940
Part of ISSN: 0091-7451
Part of ISSN: 1943-4456
Source: Self-asserted source
Gabriele Bergers

Glioblastoma: Defining Tumor Niches

Trends in Cancer
2015-12 | Journal article
DOI: 10.1016/j.trecan.2015.10.009
Part of ISSN: 2405-8033
Source: Self-asserted source
Gabriele Bergers

Tumor angiogenesis, from foe to friend

Science
2015-08-14 | Journal article
DOI: 10.1126/science.aad0862
Part of ISSN: 0036-8075
Part of ISSN: 1095-9203
Source: Self-asserted source
Gabriele Bergers

Intertwined regulation of angiogenesis and immunity by myeloid cells

Trends in Immunology
2015-04 | Journal article
DOI: 10.1016/j.it.2015.02.005
Part of ISSN: 1471-4906
Source: Self-asserted source
Gabriele Bergers

Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy

Cell Reports
2015-04 | Journal article
DOI: 10.1016/j.celrep.2015.03.055
Part of ISSN: 2211-1247
Source: Self-asserted source
Gabriele Bergers

Escape Mechanisms from Antiangiogenic Therapy: An Immune Cell’s Perspective

Advances in Experimental Medicine and Biology
2014 | Book chapter
DOI: 10.1007/978-1-4614-5915-6_4
Part of ISBN: 9781461459149
Part of ISBN: 9781461459156
Part of ISSN: 0065-2598
Part of ISSN: 2214-8019
Source: Self-asserted source
Gabriele Bergers

HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer

NMR in Biomedicine
2014-11 | Journal article
DOI: 10.1002/nbm.3198
Part of ISSN: 0952-3480
Source: Self-asserted source
Gabriele Bergers

Targeting vascular sprouts

Science
2014-06-27 | Journal article
DOI: 10.1126/science.1257071
Part of ISSN: 0036-8075
Part of ISSN: 1095-9203
Source: Self-asserted source
Gabriele Bergers

Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors

Molecular Cancer Therapeutics
2014-04 | Journal article
DOI: 10.1158/1535-7163.mct-13-0684
Part of ISSN: 1535-7163
Part of ISSN: 1538-8514
Source: Self-asserted source
Gabriele Bergers

Location, Location, Location: Macrophage Positioning within Tumors Determines Pro- or Antitumor Activity

Cancer Cell
2013-12 | Journal article
DOI: 10.1016/j.ccr.2013.11.014
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

Clinical Cancer Research
2013-04-01 | Journal article
DOI: 10.1158/1078-0432.ccr-12-1281
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Source: Self-asserted source
Gabriele Bergers

Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.

CNS oncology
2013-01-01 | Journal article
DOI: 10.2217/cns.12.36
PMID: 23750318
PMC: PMC3673744
Source: Self-asserted source
Gabriele Bergers

VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

Cancer Cell
2012-07 | Journal article
DOI: 10.1016/j.ccr.2012.05.037
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors

Cancer Cell
2011-09 | Journal article
DOI: 10.1016/j.ccr.2011.08.011
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Tumor microenvironment and progression

Journal of Surgical Oncology
2011-05-01 | Journal article
DOI: 10.1002/jso.21709
Part of ISSN: 0022-4790
Source: Self-asserted source
Gabriele Bergers

Non-Stem Cell Origin for Oligodendroglioma

Cancer Cell
2010-12 | Journal article
DOI: 10.1016/j.ccr.2010.10.033
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients

Cancer Research
2009-09-01 | Journal article
DOI: 10.1158/0008-5472.can-09-0347
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Gabriele Bergers

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

Cancer Cell
2009-03 | Journal article
DOI: 10.1016/j.ccr.2009.01.027
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Chapter 3 Bone Marrow–Derived Vascular Progenitors and Proangiogenic Monocytes in Tumors

Angiogenesis: In Vivo Systems, Part B
2008 | Book chapter
DOI: 10.1016/s0076-6879(08)03003-6
Part of ISBN: 9780123743145
Part of ISSN: 0076-6879
Source: Self-asserted source
Gabriele Bergers

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

BMC Medicine
2008-12 | Journal article
DOI: 10.1186/1741-7015-6-14
Part of ISSN: 1741-7015
Source: Self-asserted source
Gabriele Bergers

Modes of resistance to anti-angiogenic therapy

Nature Reviews Cancer
2008-08 | Journal article
DOI: 10.1038/nrc2442
Part of ISSN: 1474-175X
Part of ISSN: 1474-1768
Source: Self-asserted source
Gabriele Bergers

Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM

Neuro-Oncology
2008-06-01 | Journal article
DOI: 10.1215/15228517-2008-001
Part of ISSN: 1523-5866
Part of ISSN: 1522-8517
Source: Self-asserted source
Gabriele Bergers

HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

Cancer Cell
2008-03 | Journal article
DOI: 10.1016/j.ccr.2008.01.034
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting

PLoS Medicine
2008-01-29 | Journal article
DOI: 10.1371/journal.pmed.0050019
Part of ISSN: 1549-1676
Source: Self-asserted source
Gabriele Bergers

Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma

Cancer Research
2007-10-01 | Journal article
DOI: 10.1158/0008-5472.can-07-1316
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Gabriele Bergers

Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel–Lindau tumor suppressor gene

Oncogene
2007-07 | Journal article
DOI: 10.1038/sj.onc.1210249
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Source: Self-asserted source
Gabriele Bergers

The PTEN/Akt Pathway Dictates the Direct  V 3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo

Cancer Research
2006-11-17 | Journal article
DOI: 10.1158/0008-5472.can-06-1540
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Gabriele Bergers

The bone marrow constitutes a reservoir of pericyte progenitors

Journal of Leukocyte Biology
2006-10 | Journal article
DOI: 10.1189/jlb.0506309
Part of ISSN: 0741-5400
Source: Self-asserted source
Gabriele Bergers

Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents

Cancer and Metastasis Reviews
2006-06 | Journal article
DOI: 10.1007/s10555-006-8504-6
Part of ISSN: 0167-7659
Part of ISSN: 1573-7233
Source: Self-asserted source
Gabriele Bergers

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Cancer Cell
2005-10 | Journal article
DOI: 10.1016/j.ccr.2005.09.005
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers

PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

Nature Cell Biology
2005-09 | Journal article
DOI: 10.1038/ncb1288
Part of ISSN: 1465-7392
Part of ISSN: 1476-4679
Source: Self-asserted source
Gabriele Bergers

Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization

Blood
2005-02-01 | Journal article
DOI: 10.1182/blood-2004-06-2315
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Gabriele Bergers

Integrin  3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis: Implications for the Role of  3 Overexpression in Glioblastoma Multiforme

Cancer Research
2004-04-15 | Journal article
DOI: 10.1158/0008-5472.can-03-3354
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Gabriele Bergers

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis

Cancer Cell
2003-11 | Journal article
DOI: 10.1016/s1535-6108(03)00271-x
Part of ISSN: 1535-6108
Source: Self-asserted source
Gabriele Bergers
Items per page:
Page 1 of 2

Peer review (3 reviews for 2 publications/grants)

Review activity for Cell research (1)
Review activity for Nature (2)
How many people are using ORCID?